ASTRAZEN · AstraZeneca Pharma India Limited · Financials
Volume · Nov 13
1003
Avg daily vol (3M)
525
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
22.76B
+32.6%
FY2026
Net Income
1.88B
+62%
FY2026
Operating Cash Flow
-151.4M
-123.2%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|
| INR | 26.02B | 22.76B | 17.16B | 12.96B | 10.03B | 8.06B | 8.14B | 8.32B | 7.28B |
| INR | 200.2M | 285.8M | 399.9M | 149.41M | 162.6M | 169.49M | 201.26M | 185.84M | 149.24M |
| INR | 69.4M | 44.9M | 14.6M | 12.01M | 6.33M | 9.47M | 10.93M | 11.37M | 0 |
| INR | 2.44B | 2.52B | 1.56B | 2.2B | 1.34B | 830.36M | 1.27B | 1.14B | 726.64M |
| INR | 661.9M | 646.8M | 406.2M | 580.26M | 348.12M | 214.43M | 337.9M | 417.5M | 182.23M |
| INR | 1.78B | 1.88B | 1.16B | 1.62B | 992.93M | 615.93M | 933.04M | 722.11M | 0 |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 2.05B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.